SCHEMBL4132279

SCHEMBL4132279

CCCCCCCC/C=C\CCCCCCCC(=O)OCC(CO)(CO)COC(=O)CCCCCCC/C=C\CCCCCCCC

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DGKA P23743 1/20 0.59
PRKCE Q02156 1/20 0.57
PRKCQ Q04759 1/20 0.57
PRKCD Q05655 1/20 0.57
PRKCA P17252 1/20 0.57
MGLL Q99685 1/20 0.55
CNR2 P34972 1/20 0.54
HRH3 Q9Y5N1 1/20 0.52
TERT O14746 3/20 0.51
CYP1A2 P05177 2/20 0.51
MAPT P10636 2/20 0.51
CYP2C19 P33261 2/20 0.51
BLM P54132 2/20 0.51
HSD17B10 Q99714 2/20 0.51
FABP4 P15090 2/20 0.51
FAAH O00519 2/20 0.51
PTPN1 P18031 2/20 0.51
PPARG P37231 2/20 0.51
KMT2A Q03164 2/20 0.51
PPARD Q03181 2/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10993478 1.00 DGKA (0.59) DGKAPRKCEPRKCQPRKCDPRKCA
SCHEMBL29369084 0.97 DGKA (0.59) DGKAPRKCEPRKCQPRKCDPRKCA
SCHEMBL11784673 0.97 DGKA (0.59) DGKAPRKCEPRKCQPRKCDPRKCA
SCHEMBL26004384 0.97 DGKA (0.56) DGKAPRKCEPRKCQPRKCDPRKCA
SCHEMBL145547 0.97 DGKA (0.59) DGKAPRKCEPRKCQPRKCDPRKCA
SCHEMBL3855244 0.97 DGKA (0.59) DGKAPRKCEPRKCQPRKCDPRKCA
SCHEMBL9816852 0.97 DGKA (0.59) DGKAPRKCEPRKCQPRKCDPRKCA
SCHEMBL3856010 0.97 DGKA (0.59) DGKAPRKCEPRKCQPRKCDPRKCA
SCHEMBL16636803 0.97 DGKA (0.59) DGKAPRKCEPRKCQPRKCDPRKCA
SCHEMBL16308645 0.97 DGKA (0.59) DGKAPRKCEPRKCQPRKCDPRKCA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 69 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025043049-A2 LIPOPROTEIN-LIKE NANOPARTICLES WITH AN ORGANIC CORE AND USE THEREOF NORTHWESTERN UNIVERSITY (US) 2025-02-27 WO claimed
EP-4494632-A1 LIPOPHILIC-BASED COMPOSITION Consejo Superior de Investigaciones Científicas (CSIC) (ES) 2025-01-22 EP claimed
CN-118755041-A Fluorine-free cationic polyurethane water repellent based on long-chain alkane and preparation method thereof 中国科学院成都有机化学有限公司 2024-10-11 CN claimed
CN-118516158-A Cold rolling liquid composition and preparation method and application thereof 中国石油化工股份有限公司 2024-08-20 CN claimed
CN-118496584-A Modified cycloolefin copolymer and preparation method and application thereof 拓烯科技(衢州)有限公司 2024-08-16 CN claimed
CN-115305133-A Lubricating type electrostatic spraying anti-rust oil composition and preparation method and application thereof 中国石油化工股份有限公司 2022-11-08 CN claimed
CN-111333826-B HAA (polyurethane-acrylonitrile) cured high-leveling and thick-coating pinhole-resistant polyester resin as well as preparation method and application thereof 黄山市向荣新材料有限公司 2022-08-02 CN claimed
CN-112646351-B PPE/PS alloy material and preparation method and application thereof 金发科技股份有限公司 2022-06-10 CN claimed
CN-114196458-A Extreme pressure antiwear additive for hydraulic oil of crane 徐州徐工液压件有限公司 2022-03-18 CN claimed
CN-113999717-A Stable water-based stamping forging liquid and production process thereof 盐城杰润科技有限公司 2022-02-01 CN claimed
US-20260146144-A1 SYNERGISTIC STABILIZER COMPOSITIONS AND METHODS FOR USING SAME FOR PROTECTING ORGANIC MATERIALS FROM UV LIGHT AND THERMAL DEGRADATION CYTEC INDUSTRIES INC. (US) 2026-05-28 US disclosed
EP-4720035-A1 LIPID COMPOUNDS, COMPOSITIONS, AND USES THEREOF LIBERATE BIO, INC. (US) 2026-04-08 EP disclosed
EP-3995539-B1 GREEN PROCESSING OILS FOR ELASTOMER COMPOUNDING OLEOTECNICA S P A (IT) 2026-01-07 EP disclosed
EP-4644513-A1 LUBRICATING OIL COMPOSITION Idemitsu Kosan Co.,Ltd. (JP) 2025-11-05 EP disclosed
EP-3275448-B1 NUCLEIC ACID-CONTAINING LIPID NANOPARTICLES KYOWA KIRIN CO LTD (JP) 2025-10-29 EP disclosed
EP-1977789-A1 Method for obtaining O/W cosmetic emulsions with high water resistance 3V SIGMA S.p.A (IT) 2008-10-08 EP disclosed
US-20030103915-A1 Combinations of sunscreens 3V SIGMA S.P.A. (IT) 2003-06-05 US disclosed
EP-1300137-A2 Combinations of sunscreens 3V SIGMA S.p.A (IT) 2003-04-09 EP disclosed
US-6514485-B1 Combinations of sunscreens 3V SIGMA S.P.A. (IT) 2003-02-04 US disclosed
EP-1027883-A2 Combinations of sunscreen agents with UV-A and UV-B filtering properties 3V SIGMA S.p.A (IT) 2000-08-16 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030103915-A1 Combinations of sunscreens ERCC4, ERCC1, ERCC5 DGKA 3045/4885PRKCE 2937/4885PRKCQ 3243/4885
US-20260146144-A1 SYNERGISTIC STABILIZER COMPOSITIONS AND METHODS FOR USING SAME FOR PROTECTING ORGANIC MATERIALS FROM UV LIGHT AND THERMAL DEGRADATION RAD52, XRCC6, RAD23B DGKA 4526/4885PRKCE 4744/4885PRKCQ 4681/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.